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Abstract
Background: Atrial fibrillation (AF) is a controversial risk factor for dementia. 
Objective: The objective of this study was to assess the association between AF and dementia in  the “Sao Paulo Ageing 
& Health” (SPAH) study participants.
Methods: SPAH is a cross-sectional, population-based study of elderly people living in a deprived neighborhood in Sao 
Paulo, Brazil. Dementia diagnosis was performed according to the 10/66 study group protocol based on Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) criteria. Diagnosis of AF was made using a 12-lead electrocardiogram 
(ECG) recording, which was assessed by two cardiologists. Data on demographics and cardiovascular risk factors were 
also obtained. 
Results: Dementia was diagnosed in 66 (4.3%) and AF in 36 (2.4%) of 1,524 participants with a valid ECG. The crude 
odds ratio (OR) for dementia in participants with AF was 2.8 (95% confidence interval [CI]: 1.0–8.1; p=0.06) compared 
with individuals without AF. When analyzing data according to sex, a positive relationship was found in women (OR 4.2; 
95% CI: 1.24–15.1; p=0.03). After age-adjustment, however, this association was no longer significant (OR 2.2; 95% CI: 
0.6–8.9; p=0.26). 
Conclusion: There was no independent association between AF and dementia in this sample. The prevalence of AF may 
be low in this population owing to premature cardiovascular death. (Arq Bras Cardiol 2012;99(6):1108-1114)
Keywords: Atrial fibrillation; cardiovascular disease; dementia.
5 years (but not after 10 years) of follow-up4. Forti et al.5, 
studying individuals with mild cognitive impairment (MCI), 
found a 10.5/100 person-years conversion rate to dementia 
in this setting. The presence of AF was associated with a 
4.6-fold higher risk in this group compared with individuals 
without AF (95% CI: 1.7–12.5). 
On the other hand, Park et al. found no difference in 
cognitive function in individuals aged 60 years or older 
in the Cognition and Atrial Fibrillation Evaluation (CAFE) 
study at baseline6 or after a three-year follow-up7. The 
Vantaa 85+Study8 included residents aged 85 years or 
older (N=553) and found no difference in the frequency 
of dementia in subjects with and without AF at baseline 
(41.0% vs. 38.1%) and no difference in dementia incidence 
in individuals with AF after a mean follow-up of 3.5 years.
There is conflicting data about this subject in medical 
literature. In addition to recent reports on AF prevalence 
in the elderly9, there is no information on the association 
between AF and dementia in the Brazilian population. The 
objective of this study was to assess a possible association 
between AF and dementia in a population of elderly people 
living in a deprived neighborhood in a metropolitan area 
of the city of São Paulo. 
Introduction
It is estimated that most people with dementia already 
live in low- and middle-income nations1. However, there 
is very little data about risk factors for dementia in these 
populations2. 
The role of atrial fibrillation (AF) as a risk factor for 
dementia is still the subject of intense debate and conflicting 
results. Because dementia may be of vascular origin (even in 
the absence of documented stroke), some studies evaluated 
a possible role of AF in the development of dementia. The 
Rotterdam Study3 showed an association between AF and 
risk of dementia and/or impaired cognitive function with 
a relative risk (RR) of 2.3 and a 95% confidence interval 
(95% CI) of 1.4–3.7.  Tilvis et al. found a positive association 
between AF and cognitive decline in a population-based 
sample of 650 individuals aged 75 years and older after 
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Methods
The “São Paulo Ageing & Health” (SPAH) Study included 
a cross-sectional, one-phase, population-based study carried 
out in all residents aged 65 years or older living in an 
economically-deprived area of São Paulo, Brazil. The main 
objective of the SPAH Study was to evaluate the prevalence 
of dementia as part of a collaborative program developed by 
the 10/66 Dementia Research Group. The study protocol is 
detailed elsewhere10,11.  A substudy addressing ECG patterns 
was published previously9.
Population and sample
SPAH focused on all residents aged 65 years and older 
in 66 census sectors (smallest administrative areas) in the 
district of Butanta. The selected sectors were the most 
deprived ones in the district, including slums. Identification 
and recruitment was made by systematic knocking on doors 
of all households. Eligibility was based exclusively on age at 
time of recruitment. With the exception of institutionalized 
individuals, who were not included, all were invited to 
join the study. Whenever a census sector was selected, all 
residents were invited to participate in the study.
Of 2,266 eligible participants aged 65 years and older, 
2,072 (91.4%) consented to participate and were assessed 
for dementia by trained mental health professionals. The 
investigation for ECG changes started when the baseline 
assessment of SPAH was already underway.  To minimize 
the influence of time elapsed from baseline data collection 
and ECG recording, individuals in whom an ECG recording 
was not obtained up to one year after SPAH inclusion 
were excluded from the analysis. Reasons for exclusion are 
shown in Figure 1. Cases excluded from the analysis did not 
significantly differ from those with a valid ECG according 
to age, sex, or ethnicity.   
SPAH protocol
Subjects who agreed to participate were invited 
to participate in a 90-minute interview carried out at 
the participant’s home, approximately one week after 
recruitment by eight trained mental health workers. 
A caregiver was also identified for each participant 10. 
Information about age, ethnicity, education, socioeconomic 
status, medical history, and cognitive and daily-life function 
was collected using a standardized questionnaire. A nurse 
assistant performed anthropometric assessments and blood 
pressure measurements at the participants’ homes two to 
15 days after the assessment interview. A venous blood 
sample was obtained after an overnight fast for fasting 
blood glucose and total and HDL-cholesterol measurement. 
Diagnosis of dementia
Dementia diagnosis was based on DSM-IV criteria12. 
The presence of dementia was assessed using a dementia 
diagnostic tool developed by the 10/66 Dementia Research 
Group and validated for use in population-based studies 
of low and middle-income countries13. Information 
regarding cognitive impairment, with a detailed assessment 
of the onset and course of the dementia syndrome, was 
collected from both the participants and their caregivers. 
Diagnostic tools included the Community Screening 
Instrument for Dementia (CSI-D)14, a modified version 
of the CERAD ten-word list learning task with delayed 
recall; the animal naming verbal fluency task from the 
Consortium to Establish a Registry for Alzheimer’s Disease 
(CERAD)15, a community-directed version of the Geriatric 
Mental State, (GMS) a semi-structured clinical interview 
for the assessment of mental status16,17 and a structured 
neurological assessment to ascertain the presence of 
lateralizing signs, Parkinsonism, ataxia, apraxia, and 
primitive reflexes. The interview with caregivers consisted 
Figure 1 - Subject distribution
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of inquiries about the participant’s functional and cognitive 
performance according to the CSI-D and a brief history of 
the participant’s functioning and cognitive decline based 
on the History and Aetiology Schedule Dementia Diagnosis 
and Subtype (HAS-DDS)18, which was applied when CSI-D 
pointed towards dysfunction.  The HAS-DDS was also used 
to define probable dementia subtypes such as Alzheimer’s 
disease, vascular dementia, or mixed dementia. The latter 
was defined as the presence of characteristics from either 
previous subtypes or a previous history of Parkinsonism.
Diagnosis of atrial fibrillation
The 12-lead resting electrocardiogram recordings 
were obtained at home. Recordings were independently 
analyzed by two cardiologists (A.W. and V.S.K.) using the 
Minnesota code. Agreement on the ECG diagnosis occurred 
in 92.9% of cases. When a disagreement occurred, a new 
analysis was done by both cardiologists. A consensus was 
reached in all cases. 
Other variables
Age, education and monthly income were categorized 
for analysis. High blood pressure was defined as a positive 
medical history of high blood pressure, current treatment for 
high blood pressure, or systolic blood pressure ≥140 mmHg 
and/or diastolic blood pressure ≥90 mmHg. Diabetes mellitus 
was defined as a positive medical history of diabetes, current 
use of insulin or hypoglycemic oral drug treatment, or a fasting 
blood glucose level ≥126 mg/dl.
Ethical considerations
The study was approved by the Institutional Review Board, 
and all participants provided signed informed consent. If they 
were unable to provide consent because of mental or physical 
incapacities, a signed agreement from the caregiver was 
obtained.  When subjects were illiterate, the information sheet 
and consent form were read aloud and verbally-witnessed 
consent was acquired. 
Statistical analysis
Data entry was carried out twice using the program 
EPIDATA 3.0, and a validity check was carried out to identify 
and correct data entry errors. Data was analyzed using SPSS 
16.0. Pearson’s Chi-square test and Fisher’s exact test were 
used to compare categorical variables when appropriate. 
We also performed binary logistic regressions to evaluate the 
relationship between the presence of AF in ECG recordings and 
the diagnosis of dementia (all types), Alzheimer’s disease, and 
vascular dementia. We used three models of inclusion for these 
analyses. In Model 1, all participants with a valid ECG recording 
were included. In Model 2, we excluded those individuals 
without AF in the ECG recording, but were using amiodarone 
and/or warfarin, as this could be evidence of paroxysmal 
AF. In Model 3, we considered the subgroup of participants 
receiving amiodarone and/or warfarin as individuals with AF. 
Data were analyzed as crude ratios and after age-adjustment. 
Point estimates as well as 95% CIs are shown. P-values less than 
0.05 were considered statistically significant.
Results
Electrocardiogram recordings were obtained from 
1,524 (73.6%) individuals. Table 1 shows the baseline 
characteristics of the SPAH participants. Individuals with a 
valid ECG were then stratified by the presence of AF in the 
recording. AF was found in 37 (2,4%) subjects; 19/603 (3,2%) 
men and 18/921 (2,0%) women. Individuals with AF were 
older than those without AF (mean age, 77.7 ± 7.9 years 
vs. 72.1 ± 6.2 years; p<0.01). Of the individuals with AF, 
19 (51.4%) received antiplatelet or anticoagulant therapy, 
10 (27.0%) received aspirin, 8 (21.6%) received warfarin, 
and 1 (2.7%) received ticlopidine. Fifteen (40.5%) individuals 
received rate- and/or rhythm-control medication; 8 (21.6%) 
received digoxin, 3 (8.1%) received beta-blockers, 2 (5.4%) 
received amiodarone, 1 (2.7%) received calcium-channel 
blockers, and 1 (2.7%) received beta-blockers and calcium-
channel blockers.
Of the sample with an ECG recording, 66 (4.3%) had a 
dementia diagnosis, including 44 of 921 women (4.8%) and 
22 of 603 men (3.6%). In this ancillary study, 25 (37.9%) 
individuals had Alzheimer’s disease, 25 (37,9%) had vascular 
dementia, and 16 (24.2%) had mixed dementia. Table 2 
shows the odds ratio (crude and age-adjusted) for dementia 
(all subtypes), Alzheimer’s disease, and vascular dementia 
comparing individuals with and without AF (Model 1). Data 
are also stratified by sex. Excluding the participants who 
did not present with AF in the ECG recording, but were 
receiving amiodarone and/or warfarin (Model 2) at the time 
of evaluation did not materially alter the results. When we 
considered participants on amiodarone and/or warfarin 
treatment as individuals with AF (Model 3), no association 
reached statistical significance.
Discussion
AF and dementia are chronic disorders associated with 
high morbidity, mortality, and disability19,20,21. In our study, we 
found an association between AF and dementia in women, but 
the association vanished after adjustment for age, suggesting 
that there is no independent correlation between these 
two conditions. No association was found for men or when 
analyzing dementia subtypes.
It is difficult to establish direct comparisons among studies 
that address the relationship between AF and dementia 
because of methodological differences. One of the main 
barriers is the fact that instruments used to diagnose dementia 
and/or cognitive impairment vary widely. In low-income 
populations, education and cultural differences may also 
influence the results22. In this population-based study, we 
used a validated algorithm specifically developed for dementia 
diagnosis in low- and middle-income populations based on 
DSM-IV criteria that consists of multiple diagnostic tools and 
is corroborated by earlier studies13.
As this is a subject of debate in the medical literature and 
data from previous studies led to conflicting conclusions, it is 
important to point out reasons that may be responsible for our 
negative results and the positive results of other authors. First, 
this is a population-based study. Some authors have found a 
positive result in samples of individuals with mild cognitive 
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impairment5,23. In this type of setting, a higher conversion to 
dementia is expected, favoring positive results. Moreover, 
supposing a true association between AF and dementia exists 
only in a subgroup of individuals, this approach may “select” 
individuals in whom this process has already started, which 
also favors a positive result, leading to mistaken conclusions 
for the whole population.
Our results contrast with the findings of the Rotterdam 
Study3, which included younger individuals (inclusion 
started at age 55 years). Moreover, their results pointed to a 
stronger association between AF and dementia in younger 
individuals (aged <75 years). This is a possible explanation 
for differences observed in their study when compared 
with ours. As age advances, other mechanisms of disease 
may become prominent and an association with AF will be 
weakened. In a low-income sample such as the one in the 
present study, a survival bias due to premature all-cause24 and 
cardiovascular25 deaths is also expected. This may be at least 
partially responsible for the smaller rates of AF observed in 
our study (AF prevalence 2.0% in women and 3.2% in men), 
compared to the Cardiovascular Health Study (4.8% in women 
and 6.2% in men)26 and Rotterdam Study (7.5% in women and 
9.7% in men)27. This lower prevalence may make it difficult to 
observe an association between dementia and AF.  
Our study has some limitations. The small number of 
individuals with concomitant AF and dementia impaired the 
analysis by dementia subtypes. A cross-sectional design is 
not sufficient to establish a causal relationship between two 
conditions. However, a lack of association in this kind of study 
could indicate that a causal relationship may not exist. A single 
electrocardiogram, utilized for the diagnosis of AF, does not 
allow the diagnosis of paroxysmal AF and does not identify 
individuals successfully treated with rhythm control treatment 
strategies. However, excluding those patients with normal sinus 
rhythm who were receiving treatment potentially directed to 
paroxysmal AF (Model 2), as well as considering them as AF 
Table 1 - Baseline characteristics of study participants (n=1.524)
Characteristics With AF (n=37) Without AF (n=1.487) p
Age group (years) n (%) n (%)
65 – 69 5 (13.5) 656 (44.1) < 0.001
70 – 74 10 (27.0) 384 (25.8)
75 – 79 8 (21.6) 261 (17.6)
≥80 14 (37.8) 186 (12.5)
Gender
Female 18 (48.6) 903 (60.7) 0.14
Ethnicity
White 22 (59.5) 782 (52.6) 0.77
Mixed 12 (32.4) 447 (30.1)
Black 3 (8.1) 205 (13.8)
Asian 0 44 (3.0)
Native Brazilian 0 1 (0.1)
Others 0 8 (0.5)
Educational level
No formal education 14 (37.8) 488 (32.8) 0.27
1 – 3 years 22 (59.5) 836 (56.2)
4 or more years 1 (2.7) 163 (11.0)
Monthly income (US$)
≤ 85 10 (27.0) 361 (24.3) 0.21
86 –127 11 (29.7) 312 (21.0)
128 – 246 11 (29.7) 389 (26.2)
≥ 247 5 (13.5) 425 (28.6)
High blood pressure 27 (73.0) 1163 (79.7) 0.32
Diabetes 9 (24.3) 333 (23.2) 0.87
Dementia 4 (10.8) 62 (4.2) 0.07
AF: atrial fibrillation. For high blood pressure, diabetes, and dementia definitions, see text
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Table 2 - Crude and age-adjusted odds ratio (OR) and 95% confidence interval (95% CI) for the association between atrial fibrillation (AF) and 
dementia, Alzheimer’s disease, and vascular dementia in SPAH (n=1,524)
Condition Crude OR (95% CI)
Age-adjusted OR
(95% CI)
All
Without dementia (n = 1,458) 1.0(Reference)
1.0
(Reference)
Dementia (all types) (n = 66) 2.8 (1.0 – 8.1)p = 0.06
1.2 (0.4 – 4.0)
p = 0.73
Alzheimer’s disease (n = 25) 3.8 (0.9 – 16.6)p = 0.08
1.6 (0.3 – 7.9)
p = 0.59
Vascular dementia (n = 25) 1.8 (0.2 – 13.7)p = 0.57
1.0 (0.1 – 7.8)
p = 0.98
Women
Without dementia (n = 877) 1.0(Reference)
1.0
(Reference)
Dementia (all types) (n = 44) 4.2 (1.2 – 15.1)p = 0.03
2.2 (0.6 – 8.9)
p = 0.26
Alzheimer’s disease (n = 20) 3.0 (0.4 – 24.1)p = 0.30
1.6 (0.2 – 13.9)
p = 0.67
Vascular dementia (n = 12) 5.2 (0.6 – 43.1)p = 0.13
2.4 (0.3 – 22.9)
p =0.43
Men
Without dementia (n = 581) 1.0(Reference)
1.0
(Reference)
Dementia (all types) (n = 22) 1.5 (0.2 – 11.7)p = 0.71
0.5 (0.1 – 5.1)
p = 0.55
Alzheimer’s disease (n = 5) 7.8 (0.8 – 73.5)p = 0.07
2.2 (0.1 – 33.9)
p = 0.57
Vascular dementia (n = 13) * *
* None of the 13 men with vascular dementia had concomitant AF
patients (Model 3) did not significantly alter the results.
Conclusion
 Our study did not find an independent association 
between AF and dementia in a population-based sample 
living in a low-income area in Brazil. The prevalence of AF 
may be low in this population owing to premature death, 
especially by cardiovascular disease.
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